样式: 排序: IF: - GO 导出 标记为已读
-
The contribution of dietary advanced glycation end-products and genetic risk in the development of inflammatory bowel disease: a prospective cohort study Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-23 Fangyuan Jiang, Wenjing Yang, Yushu Cao, Xianghan Cao, Yu Zhang, Lingya Yao, Qian Cao
-
Allostatic load increases the incidence and risk of adverse prognosis in inflammatory bowel disease Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-21 Jianhui Zhao, Erxu Xue, Siyun Zhou, Meng Zhang, Fangyuan Jiang, Wei Wu, Zhanju Liu, Xue Li
-
Review article: Evidence‐based dietary management of inflammatory bowel disease Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-22 Peter R. Gibson, C. K. Yao, Emma P. Halmos
SummaryBackgroundDietary management of patients with inflammatory bowel disease (IBD) involves more than defining a therapeutic diet. The profusion of ‘expert advice’ is not necessarily built on evidence.AimsTo provide evidence‐based guidance on all clinically relevant aspects of nutritional and dietary management of patients with IBD.MethodsA comprehensive review of the published literature was made
-
Long‐term clinical outcomes of extracorporeal shockwave lithotripsy and endoscopic retrograde cholangiopancreatography for pancreatic duct stone treatment in patients with chronic pancreatitis Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-22 Yu Liu, Xiao‐Yi Yin, Jia‐Hui Cui, Teng Wang, Xiao‐Yue Feng, Jin‐Hui Yi, Jin‐Jie Xu, Song‐Ling Zhang, Pei‐Dong Han, Dan Wang, Run‐Hui Liu, Fang‐Yu Wang, Zhao‐Shen Li, Liang‐Hao Hu
-
Agile 3+ and Agile 4 scores predict chronic kidney disease development in metabolic dysfunction‐associated steatotic liver disease Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-14 Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
-
Editorial: Quantity is important! Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-13 Chee‐Kiat Tan
LINKED CONTENTThis article is linked to Sultanik et al papers. To view these articles, visit https://doi.org/10.1111/apt.18165 and https://doi.org/10.1111/apt.18216
-
Myokines are associated with progression, course and mortality in alcohol‐associated liver disease Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-13 Parminder Kaur, Nipun Verma, Pratibha Garg, Samonee Ralmilay, Aishani Wadhawan, Rohit Nadda, Jiya Prajapati, Gaurav Sharma, Sahaj Rathi, Arka De, Madhumita Premkumar, Sunil Taneja, Ashwani K. Singal, Ajay Duseja
-
Editorial: Quantity is important! Authors' reply Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-13 Marika Rudler, Dominique Thabut
LINKED CONTENTThis article is linked to Sultanik et al papers. To view these articles, visit https://doi.org/10.1111/apt.18165 and https://doi.org/10.1111/apt.18181
-
-
Editorial: NAFLD, NAFLD, or MASLD: what's in a name? Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-13 Maryam Zafer, Shravan Dave
LINKED CONTENTThis article is linked to Kim et al paper. To view this article, visit https://doi.org/10.1111/apt.18011
-
Performance of bowel preparation quality scales in patients with Crohn's disease Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-12 Virginia Solitano, Corey A. Siegel, Joshua R. Korzenik, Jennifer K. Maratt, Douglas K. Rex, Bryan Maguire, Brian Bressler, Johannes Grossmann, Rocio Sedano, John W. D. McDonald, Julie Remillard, Lisa M. Shackelton, Guangyong Zou, Brian G. Feagan, Christopher Ma, Vipul Jairath
-
Clinical trial: Effects of treatment with a vibrating capsule in patients with severe chronic constipation Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-10 Anthony Lembo, Madison Simons, Jack Loesch, Eyad Hamza, Erica Loren Graff, Eamonn Quigley, Satish S. C. Rao
-
Editorial: Tracking the course of Wilson's disease Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-09 Maryam Moini, Eve A. Roberts
LINKED CONTENTThis article is linked to Burghart et al papers. To view these articles, visit https://doi.org/10.1111/apt.18060 and https://doi.org/10.1111/apt.18203
-
Editorial: Tracking the course of Wilson's disease: Authors' reply Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-09 Lukas Burghart, Thomas Reiberger, Albert Friedrich Staettermayer
LINKED CONTENTThis article is linked to Burghart et al papers. To view these articles, visit https://doi.org/10.1111/apt.18060 and https://doi.org/10.1111/apt.18153
-
Impact of HCV eradication on recurrence pattern and long‐term outcomes in patients with HCV‐related hepatocellular carcinoma undergoing radiofrequency ablation Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-08 Kuo‐Cheng Wu, I‐Cheng Lee, Chen‐Ta Chi, Chien‐An Liu, Nai‐Chi Chiu, Shao‐Jung Hsu, Pei‐Chang Lee, Chi‐Jung Wu, Jiing‐Chyuan Luo, Ming‐Chih Hou, Yi‐Hsiang Huang
-
Cardiometabolic criteria as predictors and treatment targets of liver‐related events and cardiovascular events in metabolic dysfunction‐associated steatotic liver disease Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-08 Nobuharu Tamaki, Takefumi Kimura, Shun‐Ichi Wakabayashi, Takeji Umemura, Namiki Izumi, Rohit Loomba, Masayuki Kurosaki
-
Editorial: The future of managing drug induced liver injury Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-07 Amanda Nicoll
LINKED CONTENTThis article is linked to Conlon et al papers. To view this article, visit https://doi.org/10.1111/apt.18160
-
A personalised algorithm predicting the risk of intravenous corticosteroid failure in acute ulcerative colitis Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-07 Anthony Croft, Satomi Okano, Gunter Hartel, Anton Lord, Gareth Walker, George Tambakis, Graham Radford‐Smith
-
Letter: Light in the lumen—The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-07 R. M. Mathias, R. V. Bryant
LINKED CONTENTThis article is linked to Aliu et al papers. To view these articles, visit https://doi.org/10.1111/apt.17988 and https://doi.org/10.1111/apt.18196
-
Letter: Light in the lumen—The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease. Authors' reply Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-07 Zlatan Mujagic, Arta Aliu, Daan H. C. A. Bosch, Daniel Keszthelyi
LINKED CONTENTThis article is linked to Aliu et al papers. To view these articles, visit https://doi.org/10.1111/apt.17988 and https://doi.org/10.1111/apt.18161
-
Maladaptive weight control and eating behaviours in female adolescents/young adults are associated with increased risk of irritable bowel syndrome in adulthood: Results from the Growing Up Today Study (GUTS) Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-05 Keming Yang, Sohee Kwon, Helen Burton‐Murray, Braden Kuo, Andrew T. Chan, Alison E. Field, Kyle Staller
-
Development of hepatic fibrosis in common variable immunodeficiency‐related porto‐sinusoidal vascular disorder Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-02 Julian Hercun, Bilal Asif, Anusha Vittal, Abdel Ahmed, Harish Kumar Gopalakrishna Pillai, Jenna R. E. Bergerson, Steven Holland, Gulbu Uzel, Warren Strober, Ivan J. Fuss, Christopher Koh, David E. Kleiner, Theo Heller
-
Non-selective beta-blocker is associated with reduced mortality in critically ill patients with cirrhosis: A real-world study Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-08-01 Rahul Kumar, Su Lin, Gautam Mehta, Monica D. Mesquita, Joana A. F. Calvao, M. Faisal Sheikh, Banwari Agarwal, R. P. Mookerjee, Rajiv Jalan
-
Long-term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow-up in the SELECTION open-label long-term extension study Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-31 Brian G. Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, David Laharie, Séverine Vermeire, Silvio Danese, Edward V. Loftus, Ian Beales, Stefan Schreiber, Hyo Jong Kim, Margaux Faes, Angela de Haas, Tomasz Masior, Christine Rudolph, Laurent Peyrin-Biroulet
-
Review article: Oesophageal disorders in chronic liver disease Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-31 Francisco Idalsoaga, Luis Antonio Díaz, Gustavo Ayares, Daniel Cabrera, Javier Chahuan, Hugo Monrroy, Houssam Halawi, Marco Arrese, Juan Pablo Arab
-
Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-30 Léa Sequier, Bénédicte Caron, Damien Loeuille, Sailish Honap, Vipul Jairath, Patrick Netter, Silvio Danese, Jean Sibilia, Laurent Peyrin‐Biroulet
-
Letter: Role of Helicobacter pylori and metabolic syndrome-related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-30 Jannis Kountouras, Stergios A. Polyzos, Evangelos Kazakos, Christos Zavos, Nikolaos Grigoriadis, Ioannis S. Papanikolaou, Elisabeth Vardaka, Dimitrios Tzilves, Dimitrios Chatzopoulos, Maria Tzitiridou-Chatzopoulou, Maria Touloumtzi, Michael Doulberis, Apostolis Papaefthymiou
This article is linked to Lin et al papers. To view these articles, visit https://doi.org/10.1111/apt.17930 and https://doi.org/10.1111/apt.18182.
-
Letter: Role of Helicobacter pylori and metabolic syndrome-related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH—Authors’ reply Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-30 S. K. Bansal, M. B. Bansal
This article is linked to Bansal et al. papers. To view these articles, visit https://doi.org/10.1111/apt.17930 and https://doi.org/10.1111/apt.18124.
-
Letter: Association of serum growth differentiation factor 15 and liver‐related outcomes in patients with MASLD Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-30 Jian Wang, Tao Fan, Shaoqiu Zhang, Chao Wu, Rui Huang
LINKED CONTENTThis article is linked to Kumazaki et al papers. To view these articles, visit https://doi.org/10.1111/apt.18063 and https://doi.org/10.1111/apt.18186
-
Letter: Association between serum growth differentiation factor 15 and liver‐related outcomes in patients with MASLD—Authors' reply Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-30 Shusuke Kumazaki, Hayato Hikita, Yuki Tahata, Tetsuo Takehara
LINKED CONTENTThis article is linked to Kumazaki et al. papers. To view these articles, visit https://doi.org/10.1111/apt.18063 and https://doi.org/10.1111/apt.18150
-
Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver disease Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-29 Nina Dominik, Lorenz Balcar, Georg Semmler, Benedikt Simbrunner, Michael Schwarz, Benedikt S. Hofer, Lukas Hartl, Mathias Jachs, Bernhard Scheiner, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Alexander Pilger, Thomas Reiberger
-
Letter: Critical appraisal of biologic therapy in management of early ulcerative colitis—Addressing study limitations and the role of psychological resilience Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-29 Qing Lan, Long Guo, Zhifan Xiong
LINKED CONTENTThis article is linked to Strande et al papers. To view these articles, visit https://doi.org/10.1111/apt.18097 and https://doi.org/10.1111/apt.18187.
-
Letter: Critical appraisal of biologic therapy in early ulcerative colitis management—Addressing study limitations and the role of psychological resilience—Authors' reply Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-29 Vibeke Strande, Marte Lie Høivik, Vendel A. Kristensen
LINKED CONTENTThis article is linked to Strande et al papers. To view these articles, visit https://doi.org/10.1111/apt.18097 and https://doi.org/10.1111/apt.18156.
-
The effect of dietary emulsifiers and thickeners on intestinal barrier function and its response to acute stress in healthy adult humans: A randomised controlled feeding study Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-27 Jessica A. Fitzpatrick, Peter R. Gibson, Kirstin M. Taylor, Emma P. Halmos
-
Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid‐free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-26 Stefan Schreiber, Raymond K. Cross, Remo Panaccione, Geert D'Haens, Peter Bossuyt, Iris Dotan, Jean‐Frederic Colombel, Edouard Louis, Marla C. Dubinsky, Kristina Kligys, Ezequiel Neimark, Alexandra Song, Javier Zambrano, Jasmina Kalabic, Erica Cheng, Yafei Zhang, Marc Ferrante
-
Review article: advances in the diagnosis and management of anorectal motility disorders Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-25 Dariush Shahsavari, Satish S. C. Rao
SummaryBackgroundAnorectal motility disorders such as dyssynergic defecation (DD), faecal incontinence (FI) and anorectal pain affect 40% of the population and are a frequent reason for gastroenterology consultation. They significantly affect the quality of life and lead to psychological distress. Lack of understanding of these problems compounded by a lack of availability and knowledge of diagnostic
-
Meta‐analysis: High pooled positive predictive value of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition no‐biopsy approach for coeliac disease testing in children Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-24 Angharad Vernon‐Roberts, Sanjeev Verma, Andrew S. Day, Shaun S. C. Ho
-
-
Letter: Extreme diagnostic delay due to misdiagnosis of gastrointestinal tuberculosis later diagnosed as postoperative Crohn's disease Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-23 Abhirup Chatterjee, Ashutosh Ishan Yadav, Aravind Sekar, Harjeet Singh, Usha Dutta, Vishal Sharma
LINKED CONTENTThis article is linked to Jayasooriya et al paper. To view this article, visit https://doi.org/10.1111/apt.17370.
-
Editorial: Decoding the enigma—Navigating complexity in MASLD management Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-22 Karen Cheuk‐Ying Ho, Lung‐Yi Mak
LINKED CONTENTThis article is linked to Alkhouri et al papers. To view these articles, visit https://doi.org/10.1111/apt.18149 and https://doi.org/10.1111/apt.18185
-
Editorial: Leveraging existing mid-end ultrasound machine for point-of-care intestinal ultrasound in low-resource settings—Prospective, real-world impact on clinical decision making Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-22 Akhilesh Swaminathan, Antony B. Friedman
This article is linked to Pal et al papers. To view these articles, visit https://https://doi.org/10.1111/apt.18155 and https://doi.org/10.1111/apt.18189
-
Editorial: Leveraging existing mid-end ultrasound machine for point-of-care intestinal ultrasound in low-resource settings: Prospective, real-world impact on clinical decision making. Authors' reply Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-22 Partha Pal, Mohammad Abdul Mateen
This article is linked to Pal et al papers. To view these articles, visit https://doi.org/10.1111/apt.18155 and https://doi.org/10.1111/apt.18175
-
Editorial: Decoding the enigma—Navigating complexity in MASLD management. Authors' reply Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-22 Naim Alkhouri, Anne‐Cécile V. Bayne, Naga Chalasani
LINKED CONTENTThis article is linked to Alkhouri et al papers. To view these articles, visit https://doi.org/10.1111/apt.18149 and https://doi.org/10.1111/apt.18169
-
Prevalence and prognosis of patients with MASLD‐related cirrhosis after an ICU hospitalization in France: A single‐centre prospective study Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-22 Philippe Sultanik, Guillaume Lherault, Charlotte Bouzbib, Vlad Ratziu, Raluca Pais, Sarah Mouri, Dominique Thabut, Marika Rudler
-
Editorial: GLP-1 receptor agonists in inflammatory bowel disease—Is it time? Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-21 Konstantinos Arvanitakis, Georgios Germanidis
This article is linked to Desai et al papers. To view this article, visit https://doi.org/10.1111/apt.18138
-
Outcomes of patients with alcohol-associated hepatitis and acute kidney injury – Results from the HRS Harmony Consortium Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-15 Ann T. Ma, Andrew S. Allegretti, Giuseppe Cullaro, Tianqui Ouyang, Sumeet K. Asrani, Raymond T. Chung, Eric M. Przybyszewski, Robert M. Wilechansky, Jevon E. Robinson, Pratima Sharma, Douglas A. Simonetto, Prasun Jalal, Eric S. Orman, Hani M. Wadei, Shelsea A. St. Hillien, Danielle Saly, Nneka N. Ufere, Leigh Anne Dageforde, Kevin R. Regner, Justin M. Belcher, Kavish R. Patidar
-
Letter (brief communication): A pilot study of hemp hull bio gut fibre (BGF) to reduce intestinal permeability in IBS‐BAD Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-19 Camille Lupianez‐Merly, Kara Jencks, Saam Dilmaghani, Monique Ferber, Luma Melo, B. Jan‐Willem van Klinken, Swati Kalgaonkar, Michael Camilleri
Intestinal barrier (IB) dysfunction plays a role in pathogenesis of intestinal diseases including irritable bowel syndrome (IBS) with bile acid diarrhoea (BAD).1 Dietary nutrients or supplements including whole grains may enhance IB functions by restoring the gut microbiome, mucus layer thickness,2 and effects on tryptophan and short chain fatty acids (SCFA).3, 4 Hemp seeds provide all essential amino
-
Editorial: Trajectory of soluble programmed cell death protein-1 and ligand-1 in HBV-infected individuals treated with pegylated interferon—implications for stopping rules and the HBV cure programme Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-17 James Lok
This article is linked to Chen et al papers. To view these articles, visit https://doi.org/10.1111/apt.18131 and https://doi.org/10.1111/apt.18174
-
Editorial: Trajectory of soluble programmed cell death protein-1 and ligand-1 in HBV-infected individuals treated with pegylated interferon—Implications for stopping rules and the HBV cure programme. Authors' reply Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-17 Chan Xie
This article is linked to Chen et al papers. To view these articles, visit https://doi.org/10.1111/apt.18131 and https://doi.org/10.1111/apt.18142
-
-
Letter: Microbial manipulation for primary sclerosing cholangitis-associated inflammatory bowel disease—hope on the horizon Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-16 D. Bogatic, R. V. Bryant
This article is linked to Ricciuto et al paper. To view this article, visit https://doi.org/10.1111/apt.17936
-
Letter: Post-endoscopic management after upper gastrointestinal bleeding—Replenishment of iron loss Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-16 Palle Bager, Jens Frederik Dahlerup
This article is linked to Shung et al paper. To view this article, visit https://doi.org/10.1111/apt.17949
-
Letter: Drug interaction in resmetirom times Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-16 Xiao-Dong Zhou, Wen-Yue Liu, Giovanni Targher, Christopher D. Byrne, Ming-Hua Zheng
This article is linked to Harrison et al paper. To view this article, visit https://doi.org/10.1111/apt.17734
-
Letter: MAFLD versus MASLD—The devil lies in the details Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-16 Mohamed Alboraie, Mohamed-Naguib Wifi, Yasser Fouad
This article is linked to Kim et al paper. To view this article, visit https://doi.org/10.1111/apt.18011
-
Letter: Reflections on the role of over-the-scope clips in high-risk upper gastrointestinal bleeding—Authors' reply Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-15 Chengzhen Lyu, Daiyu Yang, Hemiao Xu, Kun He, Qiang Wang, Dong Wu
This article is linked to He et al papers. To view these articles, visit https://doi.org/10.1111/apt.18093 and https://doi.org/10.1111/apt.18145
-
Letter: Reflections on the role of over-the-scope clips in high-risk upper gastrointestinal bleeding Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-15 Yajie Wang, Yisheng Pan
This article is linked to He et al papers. To view these articles, visit https://doi.org/10.1111/apt.18093 and https://doi.org/10.1111/apt.18173
-
Faecal biomarkers for diagnosis and prediction of disease course in treatment-naïve patients with IBD Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-12 Maria Ling Lundström, Christer Peterson, Charlotte R. H. Hedin, Daniel Bergemalm, Maria Lampinen, Maria K. Magnusson, Åsa V. Keita, Robert Kruse, Carl Mårten Lindqvist, Dirk Repsilber, Mauro D'Amato, Henrik Hjortswang, Hans Strid, , Johan D. Söderholm, Lena Öhman, Per Venge, Jonas Halfvarson, Marie Carlson
-
Featured Cover Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-10 Shusuke Kumazaki, Hayato Hikita, Yuki Tahata, Ji Hyun Sung, Kenji Fukumoto, Yuta Myojin, Sadatsugu Sakane, Kazuhiro Murai, Yoichi Sasaki, Kumiko Shirai, Yoshinobu Saito, Takahiro Kodama, Naruyasu Kakita, Hirokazu Takahashi, Hidenori Toyoda, Goki Suda, Eiichi Morii, Takashi Kojima, Takeshi Ebihara, Kentaro Shimizu, Yutaka Sasaki, Tomohide Tatsumi, Tetsuo Takehara
-
Clinical characteristics and HLA associations of azithromycin-induced liver injury Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-10 Caroline Conlon, Yi-Ju Li, Jawad Ahmad, Huiman Barnhart, Robert J. Fontana, Marwan Ghabril, Paul H. Hayashi, David E. Kleiner, William M. Lee, Victor Navarro, Joseph A. Odin, Elizabeth J. Phillips, Andrew Stolz, Raj Vuppalanchi, Dina Halegoua-DeMarzio
-
The effect of vitamin E and docosahexaenoic acid ethyl ester on Metabolic Dysfunction-Associated steatotic Liver Disease (MASLD)—A randomised, double-blind, placebo-controlled, parallel-group clinical trial (PUVENAFLD) Aliment. Pharm. Ther. (IF 6.6) Pub Date : 2024-07-12 Naim Alkhouri, Deanna McCarthy, Anne-Cécile V. Bayne, Traci Blonquist, Karin Yurko-Mauro, Raj Vuppalanchi, Eric Lawitz, Naga Chalasani